Nine Masts Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Nine Masts Capital’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-200,660	Closed	-$2.87M	–	31
2020 Q4	$2.87M	Buy	200,660 +97,650	+95%	+$1.31M	2.47%	10
2020 Q3	$1.46M	Buy	+103,010	New	+$1.23M	1.15%	10
2019 Q4	–	Sell	-255,250	Closed	-$1.96M	–	189
2019 Q3	$1.96M	Buy	+255,250	New	+$1.9M	0.37%	25
2019 Q1	–	Sell	-31,965	Closed	-$241K	–	240
2018 Q4	$241K	Sell	31,965 -470,140	-94%	-$3.31M	0.04%	112
2018 Q3	$3.52M	Sell	502,105 -177,430	-26%	-$1.19M	0.96%	21
2018 Q2	$4.4M	Buy	+679,535	New	+$4.29M	0.85%	23
2018 Q1	–	Sell	-220,000	Closed	-$1.67M	–	354
2017 Q4	$1.67M	Buy	220,000 +167,000	+315%	+$1.2M	0.22%	49
2017 Q3	$380K	Buy	+53,000	New	+$381K	0.06%	65
2017 Q2	–	Sell	-245,595	Closed	-$2M	–	201
2017 Q1	$2M	Sell	245,595 -22,875	-9%	-$198K	0.34%	40
2016 Q4	$2.42M	Sell	268,470 -10,530	-4%	-$98K	0.5%	34
2016 Q3	$2.61M	Buy	279,000 +265,500	+1,967%	+$2.53M	0.52%	38
2016 Q2	$135K	Sell	13,500 -78,250	-85%	-$717K	0.03%	52
2016 Q1	$841K	Sell	91,750 -981,265	-91%	-$8.77M	0.16%	60
2015 Q4	$10.1M	Buy	+1,073,015	New	+$11.8M	2.08%	13
2015 Q3	–	Sell	-39,975	Closed	-$446K	–	84
2015 Q2	$446K	Sell	39,975 -207,470	-84%	-$2.29M	0.15%	52
2015 Q1	$2.83M	Buy	+247,445	New	+$2.62M	0.58%	24

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nine Masts Capital's RDY Position: Q1 2021 in Review

Nine Masts Capital sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 200,660 shares — an estimated $2.87M sold.

Nine Masts Capital first reported a position in RDY in Q1 2015 and held it in 16 quarters. The position peaked at $10.1M in Q4 2015. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

Nine Masts Capital reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
Nine Masts Capital sold 200,660 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $2.87M.
Nine Masts Capital first reported a position in Dr. Reddy's Laboratories in Q1 2015 and held it in 16 quarters.
Nine Masts Capital's Dr. Reddy's Laboratories position peaked at $10.1M in Q4 2015.
160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on Nine Masts Capital's 13F filing for Q1 2021, filed 14 May 2021.